REFOXY

Refoxy has created a discovery platform that permits the identification and optimization of novel FOXO3 small molecule activators that are functionally relevant across diverse disease models. F.act finder (or FOXO act ivator finder) was built on top of the pioneering work of our scientific co-founder, Prof. Wolfgang Link, and relies on a combination of phenotypic screening, unbiased assessments of FOXO3 specificity, and multiple built-in safety and counter screening measurements.

Also known as: Refoxy Pharmaceuticals, Refoxy Pharmaceuticals GmbH

Registration numbers: HRB 120133 (W)

VAT numbers: DE334216164

Primary location: Cologne Germany